Greg has devoted 20+ years to growing healthcare companies through industry and management consulting experience. Prior to founding Asymmetry Group in 2017, Greg held a variety of leadership roles at Biogen, including heading the Global Commercial Excellence & Operations functions, serving as Chief of Staff to the Chief Commercial Officer, and developing several new-to-company functions including Launch Excellence, Marketing Excellence, Patient Insights and Digital Technology & Innovation. He has also held industry leadership positions in Corporate Strategy at Life Technologies and Supply Chain Strategy at Wyeth Biopharma. Through these experiences, Greg has become adept at quickly identifying issues and opportunities, creating new capabilities, and successfully implementing these in highly matrixed companies.
Greg also spent a decade in strategic management consulting at Monitor Group (now Deloitte Consulting), serving biopharmaceutical, medical device, diagnostic and life science clients. He has been based in multiple US locations and lived in the United Kingdom serving European clients. Greg’s strategy work focused on product and franchise Commercial Strategy, Corporate Strategy, New Product Commercialization and Planning, and Business Development.
Greg has published articles and keynoted conferences. He holds an M.B.A. from the Kellogg School of Management at Northwestern University, and a B.A. in Biology and Environmental Studies from Dartmouth College.